A risk score combining quantitative hepatitis B surface antigen and core-related antigen levels to predict off-therapy relapse after cessation of nucleos(t)ide analogues in patients with chronic hepatitis B

被引:0
|
作者
Hsu, Y. -C. [1 ]
Tanaka, Y. [2 ,3 ]
Nguyen, M. [4 ]
Chang, C. -Y. [1 ]
Tai, C. -M. [5 ]
Tseng, C. -H. [5 ]
Chen, C. -C. [6 ]
Wu, M. -S. [6 ]
Lin, J. -T. [1 ]
机构
[1] Fu Jen Catholic Univ, Coll Med, New Taipei, Taiwan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan
[3] Liver Unit, Nagoya, Aichi, Japan
[4] Stanford Univ, Med Ctr, Dept Med, Palo Alto, CA 94304 USA
[5] E Da Hosp, Dept Med, Kaohsiung, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
关键词
D O I
10.1016/S0168-8278(18)31243-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-303
引用
收藏
页码:S498 / S498
页数:1
相关论文
共 50 条
  • [41] On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B
    Yu-Hua Gao
    Qing-Hua Meng
    Zhan-Qing Zhang
    Ping Zhao
    Qing-Hua Shang
    Quan Yuan
    Yao Li
    Juan Deng
    Tong Li
    Xue-En Liu
    Hui Zhuang
    World Journal of Hepatology, 2016, 8 (34) : 1511 - 1520
  • [42] Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B
    Seto, W. -K.
    Wong, D. K. -H.
    Fung, J.
    Huang, F. -Y.
    Liu, K. S. -H.
    Lai, C. -L.
    Yuen, M. -F.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (11) : 1173 - 1180
  • [43] HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy Reply
    Sonneveld, Milan Johan
    Maasoumy, Benjamin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (12) : 2681 - 2682
  • [44] Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection
    Shinkai, Noboru
    Tanaka, Yasuhiro
    Orito, Etsuro
    Ito, Kiyoaki
    Ohno, Tomoyoshi
    Hirashima, Noboru
    Hasegawa, Izumi
    Sugauchi, Fuminaka
    Ueda, Ryuzo
    Mizokamia, Masashi
    HEPATOLOGY RESEARCH, 2006, 36 (04) : 272 - 276
  • [45] The role of hepatitis B virus core-related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen-negative patients
    Huang, Pao-Yuan
    Wang, Jing-Houng
    Hung, Chao-Hung
    Lu, Sheng-Nan
    Hu, Tsung-Hui
    Chen, Chien-Hung
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (08) : 1141 - 1149
  • [46] Hepatitis B Core-Related Antigen: A Possible Indicator for the Termination of Prophylactic Nucleos(t)ide Analogue Therapy in Patients After Immunosuppressive Therapy Reponse
    Seto, Wai-Kay
    Yuen, Man-Fung
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (06): : 970 - 970
  • [47] Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
    Mak, Lung-Yi
    Wong, Danny
    Kuchta, Alison
    Hilfiker, Martina
    Hamilton, Aaron
    Chow, Ning
    Mao, XianHua
    Seto, Wai Kay
    Yuen, Man-Fung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (01) : 146 - 162
  • [48] The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogue Cessation Among Asian Chronic Hepatitis B Patients: Friend or Foe?
    Wang, Chia-Chi
    Kao, Jia-Horng
    HEPATOLOGY, 2019, 69 (04) : 1843 - 1843
  • [49] Durability after discontinuation of nucleos(t)ide therapy in hepatitis e antigen negative chronic hepatitis B patients
    Cho, Sung Won
    Kim, Soon Sun
    Lee, Dami
    Cho, Jin Hee
    Kim, Kee Bum
    Cheong, Jae Youn
    Cho, Sung Won
    HEPATOLOGY, 2012, 56 : 356A - 356A
  • [50] Serum O-glycosylated hepatitis B surface antigen levels in patients with chronic hepatitis B during nucleos(t)ide analog therapy
    Ayato Murata
    Kiyohiko Angata
    Maki Sogabe
    Shunsuke Sato
    Takafumi Ichida
    Hisashi Narimatsu
    Takuya Genda
    BMC Gastroenterology, 22